Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Bristol Myers Squibb’s subcutaneous nivolumab shows promise in Phase 3 RCC trial Bristol Myers Squibb (NYSE: BMY) has announced results from its Phase 3 CheckMate -67T trial, which could revolutionize… byPallavi MadhirajuJanuary 29, 2024